logo
FOSHAN CITY PRIUS BIO-TECH CO.,LTD
Belangrijkste producten:Spunlace niet-geweven, gezichtsmasker vel, huidverzorging gezichtsmaskers, droog masker blad, niet-geweven producten
3YRSFOSHAN CITY PRIUS BIO-TECH CO.,LTD

Overzicht van het bedrijf

Album van het bedrijf

Basisinformatie
PRIUS has been engaged in the deep processing and import & export trade of cosmetics and spunlaced nonwoven fabric materials and products since 2013. Our company imports raw materials up to five hundred tons a year, suitable for producing spunlaced nonwoven fabrics and fine ingredients for facial mask products. PRIUS BIO-TECH is committed to the R&D of cupra fiber spunlaced non-woven fabrics and facial mask sheet OEM manufacturing, two factories are located in zhejiang and guangdong, supply weight 20-120gsm, 80-320cm width of spunlaced non-woven fabrics. Prius focuses on the R&D of high-quality non-woven facial mask sheet, and has customized more than 1000 styles for many well-known brands.All products Prius produce have ISO9001,SGS, MSDS certificate and patent certificate. High quality, good service and win-win idea leads us to producing top facial mask sheet fabric.Besides, Prius has strong and scientific management system and professional development teams. Professional equipment, management and technology are our advantages. OEM and ODM customization are welcomed.
5.0/5
Zeer tevreden
1 Reviews
  • Transacties
    -
  • Reactietijd
    ≤2h
  • Reactiesnelheid
    97.06%
Bedrijfstype
Fabrikant, Overig
Land / regio
Guangdong, China
Belangrijkste productenTotaal aantal werknemers
51 - 100 People
Totale jaarlijkse omzet
Below US$1 Million
Oprichtingsjaar
2017
Certificeringen
-
Productcertificeringen
-
Patenten
-
Handelsmerken
-
Belangrijkste markten

Product Capaciteit

Factory Informatie

Fabrieksgrootte
3,000-5,000 square meters
Fabriekslocatie
Buliding 5 Meihua Industrial Park,Guangkou Road,Leiliu Shunde,Foshan,Guangdong,China
Aantal productielijnen
3
Productie op contractbasis
OEM Service Offered, Design Service Offered, Buyer Label Offered
Jaarlijkse outputwaarde
US$10 Million - US$50 Million

R & D Capaciteit

Onderzoek & Ontwikkeling

5 - 10 People